14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ANTH
Delisted

Anthera Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2019-05-02 $0.0909 $0.0925 $0.0802 $0.0849 15 877
2019-05-01 $0.0880 $0.0970 $0.0850 $0.0921 30 777
2019-04-30 $0.0720 $0.100 $0.0713 $0.0880 25 195
2019-04-29 $0.0760 $0.0950 $0.0751 $0.0751 8 663
2019-04-26 $0.0800 $0.0949 $0.0760 $0.0842 79 325
2019-04-25 $0.0777 $0.0900 $0.0777 $0.0900 12 961
2019-04-24 $0.0856 $0.0950 $0.0777 $0.0923 33 662
2019-04-23 $0.0840 $0.0970 $0.0740 $0.0900 174 934
2019-04-22 $0.0802 $0.0950 $0.0735 $0.0950 3 188
2019-04-18 $0.0800 $0.0900 $0.0710 $0.0900 4 525
2019-04-17 $0.0900 $0.0950 $0.0800 $0.0925 20 532
2019-04-16 $0.0700 $0.0950 $0.0700 $0.0892 20 228
2019-04-15 $0.0700 $0.0950 $0.0700 $0.0940 32 994
2019-04-12 $0.0805 $0.0990 $0.0802 $0.0928 7 041
2019-04-11 $0.0800 $0.0990 $0.0800 $0.0990 6 822
2019-04-10 $0.0900 $0.0950 $0.0900 $0.0945 33 561
2019-04-09 $0.0750 $0.0950 $0.0710 $0.0950 4 275
2019-04-08 $0.0800 $0.0950 $0.0750 $0.0950 8 723
2019-04-05 $0.0811 $0.100 $0.0810 $0.0822 38 546
2019-04-04 $0.0850 $0.100 $0.0850 $0.0900 105 789
2019-04-03 $0.0851 $0.0969 $0.0851 $0.0969 3 474
2019-04-02 $0.0930 $0.0990 $0.0863 $0.0990 159 650
2019-04-01 $0.0990 $0.0990 $0.0940 $0.0990 12 884
2019-03-29 $0.0940 $0.0990 $0.0940 $0.0990 13 569
2019-03-28 $0.100 $0.100 $0.0880 $0.0990 28 430
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Golden Star

Ticker Date Change Price
LXP Apr 05 0.790% $8.86
AKR Apr 05 4.23% $16.53
SARK Mar 28 12.46% $26.88
ARCC Mar 25 0.596% $20.12
STT Mar 19 3.18% $72.62
GGB Mar 19 4.45% $4.27
LNC Mar 18 2.61% $27.17
CAG Mar 18 5.46% $28.22
CMC Mar 14 4.83% $53.19
MASI Mar 14 4.47% $132.20
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT